T.D.C. has consulting arrangements with Chiesi Farma, Bristol Myers Squibb, and Agios Pharma. The author has nothing to report.
Share your take
Add a clinician perspective alongside expert commentary.
Thomas D. Coates (Wed,) studied this question.